Adare Pharmaceuticals
Adare Pharma Solutions is a global technology-driven CDMO specializing in oral dosage forms for the pharmaceutical industry. They focus on innovative solutions such as taste masking, controlled release, solubility enhancement, and patient-centric dosing. With extensive experience, they have developed and manufactured over 65 products sold in more than 100 countries, aiming to transform drug delivery and improve patients' lives.
Industries
Nr. of Employees
large (251-1000)
Adare Pharmaceuticals
Products
Oral rapid-disintegration dosage forms
Orally disintegrating dosage technology that masks taste and rapidly dissolves in the mouth to enable dosing without water for patients with swallowing difficulties.
Multiparticulate customized release platforms
Multiparticulate systems (mini‑tablets, beadlets, granules and capsule-fill multiparticulates) to deliver tailored sustained or targeted release and once‑daily dosing for high‑dose products.
Microencapsulated taste‑masked particles
Precisely coated individual drug particles to provide uniform taste masking and improved oral sensory profile while maintaining bioavailability.
Precision oral microcapsules for high drug loading and enteric/extended release
Oral microcapsule technology enabling high drug loading suitable for taste masking, enteric coatings and extended‑release applications.
Microencapsulation and microsphere technologies for injectable long‑acting delivery
Microencapsulation approaches that titrate release kinetics to enable long‑acting injectable products and sustained systemic exposure.
Controlled‑release beadlet and granule manufacturing process
Process for producing controlled‑release beadlets and granules with uniform and narrow particle size distributions to achieve predictable release profiles.
Oral rapid-disintegration dosage forms
Orally disintegrating dosage technology that masks taste and rapidly dissolves in the mouth to enable dosing without water for patients with swallowing difficulties.
Multiparticulate customized release platforms
Multiparticulate systems (mini‑tablets, beadlets, granules and capsule-fill multiparticulates) to deliver tailored sustained or targeted release and once‑daily dosing for high‑dose products.
Microencapsulated taste‑masked particles
Precisely coated individual drug particles to provide uniform taste masking and improved oral sensory profile while maintaining bioavailability.
Precision oral microcapsules for high drug loading and enteric/extended release
Oral microcapsule technology enabling high drug loading suitable for taste masking, enteric coatings and extended‑release applications.
Microencapsulation and microsphere technologies for injectable long‑acting delivery
Microencapsulation approaches that titrate release kinetics to enable long‑acting injectable products and sustained systemic exposure.
Controlled‑release beadlet and granule manufacturing process
Process for producing controlled‑release beadlets and granules with uniform and narrow particle size distributions to achieve predictable release profiles.
Services
Contract development and manufacturing (CDMO) for oral dosage forms
End-to-end product development services from formulation and analytical development through clinical and commercial manufacture for oral solid doses.
Clinical trial materials and kit assembly
Manufacture and distribution of clinical trial materials including dose‑packs and kit assemblies under GMP and non‑GMP conditions with field distribution capabilities.
Technology transfer and scale-up services
Dedicated transfer team to facilitate process transfer, data review and analytical validation to transition projects into commercial manufacturing.
Analytical testing and stability programs
Analytical services including impurity identification, stability studies across temperature ranges and testing to support regulatory submissions.
Commercial packaging, serialization and logistics
High‑speed filling and packaging lines with serialization and global logistics support for clinical and commercial supplies, including FDA-registered packaging facilities.
Nitrosamine risk assessment and mitigation services
Analytical and process-based mitigation strategies to quantify and minimize nitrosamine formation and establish long-term control approaches for regulatory compliance.
Contract development and manufacturing (CDMO) for oral dosage forms
End-to-end product development services from formulation and analytical development through clinical and commercial manufacture for oral solid doses.
Clinical trial materials and kit assembly
Manufacture and distribution of clinical trial materials including dose‑packs and kit assemblies under GMP and non‑GMP conditions with field distribution capabilities.
Technology transfer and scale-up services
Dedicated transfer team to facilitate process transfer, data review and analytical validation to transition projects into commercial manufacturing.
Analytical testing and stability programs
Analytical services including impurity identification, stability studies across temperature ranges and testing to support regulatory submissions.
Commercial packaging, serialization and logistics
High‑speed filling and packaging lines with serialization and global logistics support for clinical and commercial supplies, including FDA-registered packaging facilities.
Nitrosamine risk assessment and mitigation services
Analytical and process-based mitigation strategies to quantify and minimize nitrosamine formation and establish long-term control approaches for regulatory compliance.
Expertise Areas
- Oral solid dose formulation development
- Taste masking and microencapsulation
- Customized/controlled release and multiparticulate systems
- Solubility enhancement and amorphous solid dispersions
Key Technologies
- Microencapsulation / coacervation
- Multiparticulate systems (mini-tablets, beadlets, granules)
- Orally disintegrating tablet technologies
- Amorphous solid dispersion (spray drying / SS-SD)